Tagged Articles

Wyeth 24 articles

Pfizer Agrees to Settle Wyeth Protonix Whistleblower Complaints for $750 Million

Pfizer and the U.S government reached “an agreement in principle” Tuesday that will require the drug giant to pay $785 million to resolve a pair of whistleblower complaints that accused its Wyeth unit of cheating Medicaid out of discounts it made available to other customers. If approved, the agreement will bring to a close a decade-long legal battle between the New York-based drug giant and whistleblowers who accused it of withholding discounts from the Medicaid program for Wyeth’s oral and intravenous forms of Protonix, a drug used to treat heartburn by reducing stomach acid. The complaints against Pfizer were filed ... Read More

Mal Moore’s estate files wrongful death lawsuit against drug company

Heather Moore Cook, executor of University of Alabama Athletics Director Mal Moore’s estate, has filed a wrongful death lawsuit against the makers of a heart medication. The lawsuit claims the drug caused Mr. Moore to suffer “severe and debilitating injury to his pulmonary system, resulting in his slow and painful death.” The drug, amiodarone, also known by the brand name Cordarone, is used to treat life-threatening heart rhythm abnormalities, such as ventricular tachycardia and ventricular fibrillation. The drug is indicated for patients who have used other antiarrhythmic drugs, and is considered a “last resort” for patients with these life-threatening heart conditions. Cordarone has ... Read More

Generic drug makers failed to warn about side effects from heartburn drug Reglan

A Missouri appeals court upheld claims by two women that makers of generic versions of the heartburn drug Reglan failed to update their safety labels to warn about side effects associated with long-term use of the medication. Reglan, which is sold generically under the name metoclopramide, has been linked to a movement disorder known as tardive dyskinesia. In 2004, manufacturers of brand-name Reglan updated its safety label with the approval of the Food and Drug Administration (FDA) to warn that “Therapy should not exceed 12 weeks in duration.” Generic manufacturers were required to update their safety labels as well but ... Read More

Alabama court rules that makers of brand name drugs can be sued by generic drug users

Generic drugs should carry the same warnings as the brand name drug and, if not, then users of the generic drug can sue the name-brand drug maker for fraudulent misrepresentation, the Alabama Supreme Court ruled. The ruling comes as a response to a certified question from a U.S. District Court, which arose during a case where a plaintiff alleged that a generic version of the prescription heartburn drug Reglan caused him to develop a movement disorder called Tardive Dyskinesia. The plaintiff sued the brand name maker, Wyeth, alleging that the company failed to warn both doctors and patients of the ... Read More

Jurors award Utah woman $5.1 million in HRT-breast-cancer case

A Utah woman was awarded $5.1 million in compensatory damages by a federal jury that found hormone replacement therapy (HRT) drugs caused her to develop breast cancer, and that the drug companies who developed and marketed HRT were negligent because they failed to adequately warn users of the risks associated with the menopause treatment. The plaintiff, 73-year-old Toshiko Okunda, filed her lawsuit in 2004. She had a hysterectomy in 1985 at the age of 47, and because of severe menopausal symptoms, was prescribed over the next 17 years various doses and combinations of HRT including Premarin, Provera and Prempro. In ... Read More

Unprofitable antivenom business leads to dangerous shortage

Summer is the perfect time to experience the great outdoors, but you may want to use caution when you come in contact with nature’s creatures. It’s frightening enough to encounter dangerous snakes, spiders or scorpions while camping or hiking, but if you get bitten you know you can count on hospitals to inject antivenom into your veins to counter any ill effects. What you probably don’t know is that the supply of many life-saving antivenoms is running out and drug companies just don’t think it’s profitable enough to keep on producing it. Take the coral snake. The brightly colored reptile ... Read More

Generic drug makers not absolved of liability

U.S. District Judge Berle M. Schiller has ruled that manufacturers of generic drugs are not protected from lawsuits even if the Food and Drug Administration (FDA) certifies them as the “bioequivalent” of their brand name predecessors. The lawsuit involved consumers who were previously taking the brand name antidepressant Wellbutrin. The defendants allege after switching to a generic version of the drug, buproprion, made by Teva Pharmaceuticals and Impax Laboratories, they experienced side effects. The lawsuit contends Teva and Impax became aware of the side effects but failed to warn consumers. While the active ingredient in Wellbutin and buproprion is the ... Read More

Supreme Court considers whether generic Reglan makers can be sued

The U.S. Supreme Court this week asked the Obama administration to comment on whether it believes generic drug companies can be sued over allegations that they inadequately labeled their products. The question arose after an appeals court reinstated a lawsuit by a woman who claimed she developed a severe neurological movement disorder after taking generic versions of the heartburn drug Reglan (metoclopramide). The lawsuit had been previously dismissed by a trial judge. Though the drugs have warning labels, the woman claims she was not adequately warned of the potential for serious side effects of the drug she was prescribed, in ... Read More

Generic Reglan makers released from Tardive Dyskinesia lawsuit

Wyeth, Inc. and Schwarz Pharma Inc. have been dismissed from a lawsuit filed in Texas involving the drug company’s Reglan (metoclopramide), a medicine used to treat gastrointestinal conditions. The lawsuit alleged that the drug caused the plaintiff to develop a severe movement disorder known as Tardive Dyskinesia. However, the case will proceed against Activis-Elizabeth, L.L.C., makers of a generic version of metoclopramide that the plaintiff was taking. Wyeth and Schwarz originally developed the brand-name metoclopramide, Reglan. They were released from litigation by U.S. District Judge Marcia A. Crone. The case is expected to be ready for trial by January 2011. ... Read More

Women on HRT who experience breast tenderness at greater risk of cancer

Women who reported new-onset breast tenderness following use of estrogen-plus-progestin hormone replacement therapy (HRT) were at a much greater risk of developing breast cancer than women on the same HRT who did not report tenderness in their breasts, according to a study by researchers from the David Geffen School of Medicine at the University of California – Los Angeles. The study was based on data from the Women’s Health Initiative (WHI), a research project into the mortality and morbidity of menopausal and post-menopausal women. One aspect of WHI looked into the benefits of HRT, but was halted in its early ... Read More